EMN · Eastman Chemical Company

Eastman Chemical Company's Q1 2026 results reflected a 5% YoY sales revenue decline to $2,177 million, driven by 4% lower volume/mix from acetate tow destocking and weak consumer discretionary demand, plus 4% lower prices amid soft commodity conditions, partially offset by 3% favorable FX. GAAP EBIT fell to $188 million from $302 million, with adjusted EBIT at $200 million versus $311 million, as lower Chemical Intermediates spreads, Fibers volume declines, Advanced Materials underutilization from Winter Storm Fern and inventory shifts, and higher energy costs outweighed cost reductions and tariff refunds. Segment-wise, Advanced Materials revenue dipped 1% on lower prices; Additives & Functional Products rose 1% on FX; Fibers plunged 22% on 19% volume drop from Middle East conflict and destocking; Chemical Intermediates fell 9% but saw March tightening. CEO Mark Costa highlighted sequential >10% specialty volume/mix gains, 240 bps adjusted EBIT margin expansion via disciplined pricing and volumes, and swift supply securing amid Middle East disruptions. Cash used in operations improved to $137 million from $167 million, with $96 million returned via dividends. For 2026, management targets $125-$150 million cost savings net of inflation, ~$400 million capex, lower shutdown costs, and earnings growth, viewing the conflict as net positive especially for Chemical Intermediates margins. Q2 adjusted EPS is guided at $1.70-$1.90, balancing volume tailwinds, specialty price hikes matching input inflation, and Chemical spreads gains against $45 million maintenance headwinds, while full-year cash flow aims to match 2025 levels despite working capital pressures.